Abingworth as of Sept. 30, 2011
Portfolio Holdings for Abingworth
Abingworth holds 26 positions in its portfolio as reported in the September 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corporation | 46.9 | $73M | 7.9M | 9.20 | |
| Alnylam Pharmaceuticals (ALNY) | 7.7 | $12M | 1.8M | 6.54 | |
| Incyte Corporation (INCY) | 7.5 | $12M | 830k | 13.97 | |
| Micromet | 6.5 | $10M | 2.1M | 4.79 | |
| Astex Pharmaceuticals | 5.5 | $8.5M | 4.5M | 1.90 | |
| OncoGenex Pharmaceuticals | 3.8 | $5.9M | 604k | 9.75 | |
| Celgene Corporation | 3.6 | $5.6M | 91k | 61.92 | |
| Zogenix | 2.8 | $4.3M | 2.3M | 1.85 | |
| NPS Pharmaceuticals | 2.1 | $3.2M | 498k | 6.50 | |
| Nektar Therapeutics (NKTR) | 2.1 | $3.2M | 664k | 4.84 | |
| Alexza Pharmaceuticals | 2.0 | $3.1M | 2.9M | 1.08 | |
| Novavax | 1.6 | $2.4M | 1.5M | 1.60 | |
| Exelixis (EXEL) | 1.5 | $2.3M | 415k | 5.45 | |
| ISIS Pharmaceuticals | 1.2 | $1.8M | 268k | 6.77 | |
| Medicines Company | 1.0 | $1.6M | 107k | 14.86 | |
| Cardiome Pharma Corp | 1.0 | $1.6M | 481k | 3.29 | |
| Isis Pharmaceuticals Inc Del note 2.625% 2/1 | 0.7 | $1.1M | 1.3k | 879.69 | |
| Zalicus | 0.6 | $847k | 864k | 0.98 | |
| Trimeris | 0.5 | $803k | 320k | 2.51 | |
| Celldex Therapeutics | 0.5 | $783k | 343k | 2.28 | |
| Cornerstone Therapeutics | 0.3 | $541k | 85k | 6.38 | |
| Allos Therapeutics | 0.3 | $485k | 265k | 1.83 | |
| AVANIR Pharmaceuticals | 0.2 | $321k | 113k | 2.85 | |
| Sunesis Pharmaceuticals | 0.1 | $153k | 129k | 1.18 | |
| EntreMed | 0.1 | $103k | 71k | 1.46 | |
| Poniard Pharmaceuticals (PARD) | 0.0 | $22k | 182k | 0.12 |
